Trump Administration Drops Plans to Impose Tariffs on Generic Drugs: A Positive Development for Indian Pharmaceutical Industry

Oct 10, 2025 06:25 pm CST

The Trump administration has decided against implementing tariffs on generic drugs imported from foreign countries, providing relief to both Indian pharmaceutical manufacturers, who supply nearly half of all generic prescriptions in the US market, and American consumers who depend on affordable medications. This decision comes after President Trump had previously announced 100 percent tariffs on branded drugs starting October 1.